These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37095536)

  • 1. Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis.
    Yin JX; Agbana YL; Sun ZS; Fei SW; Zhao HQ; Zhou XN; Chen JH; Kassegne K
    Infect Dis Poverty; 2023 Apr; 12(1):43. PubMed ID: 37095536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of blood interleukin-4 levels concerning malaria infection and severity.
    Kotepui KU; Thirarattanasunthon P; Rattaprasert P; Kotepui M
    Malar J; 2022 Jul; 21(1):217. PubMed ID: 35820892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of serum interleukin-1β levels as a potential indicator for malarial infection and severe malaria: a meta-analysis.
    Mahittikorn A; Kwankaew P; Rattaprasert P; Kotepui KU; Masangkay FR; Kotepui M
    Malar J; 2022 Oct; 21(1):308. PubMed ID: 36309676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Peluso MJ; Lu S; Tang AF; Durstenfeld MS; Ho HE; Goldberg SA; Forman CA; Munter SE; Hoh R; Tai V; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Greenhouse B; Hunt PW; Hsue PY; Martin JN; Daniel Kelly J; Glidden DV; Deeks SG; Henrich TJ
    J Infect Dis; 2021 Dec; 224(11):1839-1848. PubMed ID: 34677601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis.
    Liu M; Wang H; Liu L; Cui S; Huo X; Xiao Z; Zhao Y; Wang B; Zhang G; Wang N
    Front Immunol; 2022; 13():1046352. PubMed ID: 36389759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated interleukin-6 and adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates.
    Zhang P; Shi L; Xu J; Wang Y; Yang H
    Immunogenetics; 2020 Oct; 72(8):431-437. PubMed ID: 33067641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Patel UK; Mehta N; Patel A; Patel N; Ortiz JF; Khurana M; Urhoghide E; Parulekar A; Bhriguvanshi A; Patel N; Mistry AM; Patel R; Arumaithurai K; Shah S
    Cureus; 2022 Sep; 14(9):e29694. PubMed ID: 36321004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue outcomes following COVID-19: a systematic review and meta-analysis.
    Poole-Wright K; Guennouni I; Sterry O; Evans RA; Gaughran F; Chalder T
    BMJ Open; 2023 Apr; 13(4):e063969. PubMed ID: 37185637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.
    Yuan N; Lv ZH; Sun CR; Wen YY; Tao TY; Qian D; Tao FP; Yu JH
    Front Public Health; 2023; 11():1112383. PubMed ID: 36875356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17A in COVID-19 Cases: a meta-analysis.
    Fadlallah S; Sham Eddin MS; Rahal EA
    J Infect Dev Ctries; 2021 Nov; 15(11):1630-1639. PubMed ID: 34898490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.
    Watanabe A; Iwagami M; Yasuhara J; Takagi H; Kuno T
    Vaccine; 2023 Mar; 41(11):1783-1790. PubMed ID: 36774332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in outcome of invasive mechanical ventilation between different countries for patients with severe COVID-19: A systematic review and meta-analysis.
    Elsayed HH; Hassaballa AS; Ahmed TA; Gumaa M; Sharkawy HY; Moharram AA
    PLoS One; 2021; 16(6):e0252760. PubMed ID: 34086779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of telecardiac rehabilitation with centre-based cardiac rehabilitation and usual care: a protocol for systematic review including a meta-analysis.
    Bashir Z; Shahab A; Imran H
    Open Heart; 2022 Aug; 9(2):. PubMed ID: 35961694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cancer on the severity of disease in patients affected with COVID-19: an umbrella review and meta-meta-analysis of systematic reviews and meta-analyses involving 1,064,476 participants.
    Arayici ME; Basbinar Y; Ellidokuz H
    Clin Exp Med; 2023 Oct; 23(6):2221-2229. PubMed ID: 36207550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 in Covid-19: A systematic review and meta-analysis.
    Coomes EA; Haghbayan H
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32845568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review.
    Rezaei Tolzali MM; Noori M; Shokri P; Rahmani S; Khanzadeh S; Nejadghaderi SA; Fazlollahi A; Sullman MJM; Singh K; Kolahi AA; Arshi S; Safiri S
    Rev Med Virol; 2022 Nov; 32(6):e2388. PubMed ID: 36029180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.
    Lee JH; Yim JJ; Park J
    Respir Res; 2022 Sep; 23(1):233. PubMed ID: 36068582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.